Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Aebischer

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Nature|January 20, 2012
Philanthropy: The price of charityPatrick Aebischer
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2008
Conditional gene expression and knockdown using lentivirus vectors encoding shRNAJolanta Szulc, Patrick Aebischer
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAiChris Towne, Patrick Aebischer
Neurobiology of Disease|January 10, 2012
Use of viral vectors to create animal models for Parkinson's diseaseKarin Löw, Patrick Aebischer
Scientific American|November 10, 2007
Playng defense against Lou Gehrig's diseasePatrick Aebischer, Ann C Kato
Xenotransplantation|February 18, 2003
Cellular implants: pioneers in xenotransplantation?Bernard L Schneider, Patrick Aebischer
Wiener Klinische Wochenschrift|December 1, 2006
Viral vectors as a tool to model and treat Parkinson's diseaseJean-Charles Bensadoun, Patrick Aebischer
Parkinsonism & Related Disorders|July 1, 2008
Viral vectors, animal models and new therapies for Parkinson's diseaseBernard Schneider, Romain Zufferey, Patrick Aebischer
Human Gene Therapy|April 23, 2013
Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particlesKarin Löw, Patrick Aebischer, Bernard L Schneider
Current Biology : CB|February 20, 2004
Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson diseaseAli Sajadi, Bernard L Schneider, Patrick Aebischer
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Nature|January 20, 2012
Philanthropy: The price of charityPatrick Aebischer
Methods in Molecular Biology (Clifton, N.J.)|May 13, 2008
Conditional gene expression and knockdown using lentivirus vectors encoding shRNAJolanta Szulc, Patrick Aebischer
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAiChris Towne, Patrick Aebischer
Neurobiology of Disease|January 10, 2012
Use of viral vectors to create animal models for Parkinson's diseaseKarin Löw, Patrick Aebischer
Scientific American|November 10, 2007
Playng defense against Lou Gehrig's diseasePatrick Aebischer, Ann C Kato
Xenotransplantation|February 18, 2003
Cellular implants: pioneers in xenotransplantation?Bernard L Schneider, Patrick Aebischer
Wiener Klinische Wochenschrift|December 1, 2006
Viral vectors as a tool to model and treat Parkinson's diseaseJean-Charles Bensadoun, Patrick Aebischer
Parkinsonism & Related Disorders|July 1, 2008
Viral vectors, animal models and new therapies for Parkinson's diseaseBernard Schneider, Romain Zufferey, Patrick Aebischer
Human Gene Therapy|April 23, 2013
Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particlesKarin Löw, Patrick Aebischer, Bernard L Schneider
Current Biology : CB|February 20, 2004
Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson diseaseAli Sajadi, Bernard L Schneider, Patrick Aebischer
Pageof 10